Infusion therapy of preeclampsia in the perioperative period
The article presents current views on the pathogenesis of preeclampsia (gestosis) according to WHO's classification, examines the basic principles of administering infusion therapy with hydroxyethyl starch (HES) medications. The major representatives of this class of drugs are discussed, namely: composition, action, benefits, shortcomings, prospects for using in interrelation with the basic pathogenetic mechanisms of development of this complication. The review presents information about new methods of diagnosing the severity of gestosis (investigation of inflammatory mediators in blood and instrumental, noninvasive detection of body fluids), guided by the findings of which modern obstetrics might reduce the number of iatrogenic mistakes of infusion therapy and enhance its efficacy.